PharmaCyte Biotech to Attend J.P. Morgan Healthcare Conference
SILVER SPRING, Md., Jan. 07, 2016 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today the Company’s Chief Executive Officer, Kenneth L. Waggoner, will attend the 34th Annual J.P. Morgan Healthcare Conference in San
Read more →